Eli Lilly and CompanyLLYNYSE
Loading
Gross Profit Growth AcceleratingAccelerating
Percentile Rank74
3Y CAGR+19.5%
5Y CAGR-15.9%
Year-over-Year Change
Year-over-year gross profit growth rate
3Y CAGR
+19.5%/yr
Quarterly compound
5Y CAGR
-15.9%/yr
Recent acceleration
Percentile
P74
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 12.44% |
| Q3 2025 | 11.31% |
| Q2 2025 | 24.81% |
| Q1 2025 | -5.61% |
| Q4 2024 | 20.08% |
| Q3 2024 | 1.49% |
| Q2 2024 | 28.73% |
| Q1 2024 | -6.22% |
| Q4 2023 | -0.96% |
| Q3 2023 | 17.43% |
| Q2 2023 | 21.96% |
| Q1 2023 | -7.31% |
| Q4 2022 | 7.30% |
| Q3 2022 | 6.03% |
| Q2 2022 | -11.86% |
| Q1 2022 | -3.56% |
| Q4 2021 | 11.38% |
| Q3 2021 | 11.60% |
| Q2 2021 | -2.84% |
| Q1 2021 | -13.87% |
| Q4 2020 | 29.59% |
| Q3 2020 | 3.20% |
| Q2 2020 | -7.91% |
| Q1 2020 | -3.86% |
| Q4 2019 | 12.32% |
| Q3 2019 | -4.66% |
| Q2 2019 | 14.12% |
| Q1 2019 | -18.40% |
| Q4 2018 | 16.63% |
| Q3 2018 | -4.52% |
| Q2 2018 | 14.52% |
| Q1 2018 | -16.24% |
| Q4 2017 | 11.40% |
| Q3 2017 | -4.25% |
| Q2 2017 | 9.59% |
| Q1 2017 | -9.64% |
| Q4 2016 | 13.29% |
| Q3 2016 | -3.78% |
| Q2 2016 | 11.23% |
| Q1 2016 | -11.15% |